p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women

K Servomaa¹, A Kiuru², V-M Kosma⁴, P Hirvikoski⁴ and T Rytömaa³

¹ North Savo Regional Environment Centre, PO Box 1049, FIN-70210 Kuopio, Finland
² Radiation and Nuclear Safety Authority, PO Box 14, FIN-00881 Helsinki, Finland
³ Department of Environmental Sciences, University of Kuopio, PO Box 1627, FIN -70211 Kuopio, Finland
⁴ Department of Pathology and Forensic Medicine, University of Kuopio and University Hospital, PO Box 1627, FIN-70211 Kuopio, Finland

Correspondence to:
Dr Servomaa email: kristina.servomaa{at}vyh.fi

Aims/Background—The aim of this study was to identify p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mutation patterns might give clues to aetiological factors when comparisons are made with other human tumours.

Methods—Of 134 women with carcinoma of the rectum, paraffin wax embedded specimens of the tumour tissue were obtained from 118 patients. Genomic DNA was extracted, and exons 4–8 of the p53 gene and codons 12/13 and 61 of the K-ras gene were amplified, and analysed for mutations by single strand conformation polymorphism and direct sequencing. The production of p53 and K-ras proteins was studied by immunohistochemistry.

Results—The overall crude frequency for mutations in the p53 gene was 35% but the true frequency appears to be higher (up to 56%). In the K-ras gene, the mutation frequency (15%) was significantly lower than that reported for colon cancer. In the p53 gene, the mutation frequency increased significantly with patient age. In a high proportion of patients (14%) the rectal tumours contained small subclones of tumour cells that displayed extremely rare mutations at codons 110 and 232 of the p53 gene. Hot spot codon 175 mutations were significantly less common in rectal cancer than in cancer of the colon.

Conclusions—Rectal cancer among Finnish women has characteristics in the mutations of the p53 and K-ras genes that are uncommon in other human tumours, including cancer of the colon. A biological explanation of these findings is not clear at present, but might be associated with an unidentified genetic factor in Finland.

Key Words: p53 • K-ras • rectal carcinoma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Cohen, S. J., Cohen, R. B., Meropol, N. J. (2005). Targeting Signal Transduction Pathways in Colorectal Cancer--More Than Skin Deep. JCO 23: 5374-5385 [Abstract] [Full Text]  
• Colombino, M., Cossu, A., Manca, A., Dedola, M. F., Giordano, M., Scintu, F., Curci, A., Avallone, A., Comella, G., Amoruso, M., Margari, A., Bonomo, G. M., Castriota, M., Tanda, F., Palmieri, G. (2002). Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma. Ann Oncol 13: 1447-1453 [Abstract] [Full Text]  
• Wong, R.-H., Du, C.-L., Wang, J.-D., Chan, C.-C., Luo, J.-C. J., Cheng, T.-J. (2002). XRCC1 and CYP2E1 Polymorphisms as Susceptibility Factors of Plasma Mutant p53 Protein and Anti-p53 Antibody Expression in Vinyl Chloride Monomer-exposed Polyvinyl Chloride Workers. Cancer Epidemiol. Biomarkers Prev. 11: 475-482 [Abstract] [Full Text]  
• Srivastava, S., Verma, M., Henson, D. E. (2001). Biomarkers for Early Detection of Colon Cancer. Clin. Cancer Res. 7: 1118-1126 [Abstract] [Full Text]